SEC ownership of 89bio, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001785173.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

SUVRETTA CAPITAL MANAGEMENT, LLC

Comparable rows

5/9

Latest evidence

30 Oct 2025

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
5 of 9
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
VANGUARD GROUP INC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Oct 2025
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001785173
Issuer location
San Francisco, CA

Ownership snapshot

Top shareholders of 89bio, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
SUVRETTA CAPITAL MANAGEME...
Comparable rows
5/9
Latest evidence
30 Oct 2025
13D/G 3/4/5 Lead comparable stake: 5.6% 4 rows are not safely comparable across share classes. 13D/G row: VANGUARD GROUP INC Showing 1-8 of 9 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 5.6%.

5 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership Top 5
VANGUARD GROUP INC 5.6%
SUVRETTA CAPITAL MANAGEMENT, LLC 5.6%
JANUS HENDERSON GROUP PLC 3.6%
BIOTECHNOLOGY VALUE FUND L P 3.6%
RTW INVESTMENTS, LP 1.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 9 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13D/G
The Vanguard Group
5.6%
$80,937,952
8,242,154 shares
$0 30 Jun 2025
SUVRETTA CAPITAL MANAGEMENT, LLC
13D/G
5.6%
$121,716,000
8,280,000 shares
-$93,071,712 30 Sep 2025
JANUS HENDERSON GROUP PLC
13D/G
3.6%
$79,060,933
5,378,185 shares
-$226,534,240 30 Sep 2025
BIOTECHNOLOGY VALUE FUND L P
13D/G
BVF PARTNERS L P/IL
3.6%
$29,903,806
4,333,885 shares
$0 31 Dec 2024
RTW INVESTMENTS, LP
13D/G
1.3%
$13,575,936
1,967,527 shares
$0 31 Mar 2025
RA CAPITAL MANAGEMENT, L.P.
3/4/5
Director, 10%+ Owner
$36,809,857
30 Oct 2025
ORBIMED ADVISORS LLC
3/4/5
10%+ Owner
class O/S missing
$21,093,397
1,829,436 shares
25 Jan 2022
Gregory Grunberg
3/4/5
Director, 10%+ Owner
class O/S missing
27,400 shares
09 Feb 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$115,280.

Buys
$0
Insiders: 0
Sells
$115,280
Insiders: 1
Net
-$115,280
Shares: -10,461
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 10,461
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 10,461 $0 $115,280 -$115,280

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-17 of 17 reporting-owner rows connected to 89bio, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
17
Largest Forms 3/4/5 holder
RA CAPITAL MANAGEMENT, L.P.
Net 12M change
-$115,280
Latest report
30 Oct 2025
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner $36,809,857 Mixed 30 Oct 2025
ORBIMED ADVISORS LLC 10%+ Owner $21,093,397 Mixed 25 Jan 2022
Ram Waisbourd Chief Operating Officer and Chief Business Officer $100,888 Mixed 17 Feb 2022
Charles McWherter Director $0 Mixed 30 Oct 2025
Quoc Le-Nguyen Chief Technical Operations Officer $0 -$115,280 -100% Mixed 30 Oct 2025
Michael R. Hayden Director $0 Mixed 30 Oct 2025
Francis Willard Sarena Chief Operating Officer $0 Mixed 30 Oct 2025
Harry H. Mansbach Chief Medical Officer $0 Mixed 30 Oct 2025
Rohan Palekar Chief Executive Officer, Director $0 Mixed 30 Oct 2025
Ryan Martins Chief Financial Officer $0 Mixed 30 Oct 2025
Gregory Grunberg Director, 10%+ Owner Mixed 09 Feb 2023
Derek DiRocco Director Mixed 30 Oct 2025
Lota S. Zoth Director Mixed 30 Oct 2025
Martin Babler Director Mixed 30 Oct 2025
Kathleen Laporte Director Mixed 30 Oct 2025
Edward Morrow Atkinson III Director Mixed 30 Oct 2025
Steven Altschuler Director Mixed 30 Oct 2025

Recent insider transactions for 89bio, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Ra Capital Management, L.P. ETNB Common Stock Disposed to Issuer -100% -19,889,683 0 30 Oct 2025 See Footnotes
Ra Capital Management, L.P. ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -180,450 0 30 Oct 2025 See footnotes
Ra Capital Management, L.P. ETNB Pre-Funded Warrants (Right to Buy) Disposed to Issuer -100% -4,331,081 0 30 Oct 2025 See footnotes
Kathleen LaPorte ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -166,450 0 30 Oct 2025 Direct
Michael R. Hayden ETNB Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -165,516 0 30 Oct 2025 See footnote
Michael R. Hayden ETNB Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -80,904 0 30 Oct 2025 Direct
Michael R. Hayden ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -233,760 0 30 Oct 2025 Direct
Ryan Martins ETNB Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -374,295 0 30 Oct 2025 Direct
Ryan Martins ETNB Common Stock Award 10.3% 35,000 374,295 30 Oct 2025 Direct
Ryan Martins ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -738,102 0 30 Oct 2025 Direct
Steven M. Altschuler ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -213,450 0 30 Oct 2025 Direct
Rohan Palekar ETNB Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -934,273 0 30 Oct 2025 Direct
Rohan Palekar ETNB Common Stock Award 15.4% 125,000 934,273 30 Oct 2025 Direct
Rohan Palekar ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -2,599,223 0 30 Oct 2025 Direct
Charles McWherter ETNB Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -25,000 0 30 Oct 2025 Direct
Charles McWherter ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -124,100 0 30 Oct 2025 Direct
Edward Morrow Atkinson III ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -148,950 0 30 Oct 2025 Direct
Lota S. Zoth ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -186,450 0 30 Oct 2025 Direct
Quoc Le-Nguyen ETNB Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -13,694 0 30 Oct 2025 By Spouse
Quoc Le-Nguyen ETNB Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -351,684 0 30 Oct 2025 Direct
Quoc Le-Nguyen ETNB Common Stock Award 16.6% 50,000 351,684 30 Oct 2025 Direct
Quoc Le-Nguyen ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -43,900 0 30 Oct 2025 By Spouse
Quoc Le-Nguyen ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -829,875 0 30 Oct 2025 Direct
Martin Babler ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -124,100 0 30 Oct 2025 Direct
Derek DiRocco ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -19,500 0 30 Oct 2025 See footnote
Derek DiRocco ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -160,950 0 30 Oct 2025 Direct
Francis Willard Sarena ETNB Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -75,310 0 30 Oct 2025 Direct
Francis Willard Sarena ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -565,000 0 30 Oct 2025 Direct
Harry H. Mansbach ETNB Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -352,656 0 30 Oct 2025 Direct
Harry H. Mansbach ETNB Common Stock Award 16.5% 50,000 352,656 30 Oct 2025 Direct
Harry H. Mansbach ETNB Stock Option (Right to Buy) Disposed to Issuer -100% -954,741 0 30 Oct 2025 Direct
Ryan Martins ETNB Common Stock Options Exercise 31.3% 80,799 339,295 22 Oct 2025 Direct
Ryan Martins ETNB Stock Option (Right to Buy) Options Exercise -100% -80,799 0 22 Oct 2025 Direct
Francis Willard Sarena ETNB Common Stock Tax liability -3.86% -2,979 74,231 05 Aug 2025 Direct
Quoc Le-Nguyen ETNB Common Stock Tax liability -3.67% -522 13,694 01 Aug 2025 By Spouse
Quoc Le-Nguyen ETNB Common Stock Tax liability -2.48% -7,680 301,684 01 Aug 2025 Direct
Harry H. Mansbach ETNB Common Stock Tax liability -2.47% -7,680 302,656 01 Aug 2025 Direct
Ryan Martins ETNB Common Stock Tax liability -2.94% -7,680 253,496 01 Aug 2025 Direct
Francis Willard Sarena ETNB Common Stock Tax liability -3.99% -3,206 77,210 01 Aug 2025 Direct
Rohan Palekar ETNB Common Stock Tax liability -6.46% -55,836 808,070 01 Aug 2025 Direct
Quoc Le-Nguyen ETNB Common Stock Sale -3.27% $115,280 $11.02 -10,461 309,364 15 Jul 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .